Crossmark

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

Published Online: 2016-02-17

Published Print: 2016-12

Authors

Wattmo, Carina

Minthon, Lennart

Wallin, Åsa K.
Funding

Funding for this research was provided by:

Alzheimerfonden (Alzheimer Foundation), Sweden

Stiftelsen Gamla Tjänarinnor (Foundation of Old Servants), Sweden

Greta och Johan Kocks stiftelse (Fromma Foundation), Sweden

ALF young researcher grant from Region Skåne, Sweden
License Information

Text and Data Mining valid from 2016-02-17

Version of Record valid from 2016-02-17
More Information

Article History

Received: 24 June 2015

Accepted: 4 January 2016

First Online: 17 February 2016

Document is current